Intratumoral (but not s.c.)treatment with a cocktail of rVVs encoding GM-CSF and relevant antigen-encoding genes resulted in a tumor specific systemic immune response, but was still unable to cause tumor regression [30]. Here, CSF2 is linked to neoplasm.